NCT02051166|CompletedDMC
Clinical Practice of AECOPD Management in China
A Non Interventional, Retrospective Study on AECOPD Treatment Status in China
Loading search results
A Non Interventional, Retrospective Study on AECOPD Treatment Status in China
Sponsor study identifier
observational
5,095
1 country
13
Study Start
February 2014
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
August 2014
Actual (reported)Study Completion
August 2014
Actual (reported)The purpose of this study is observe clinical practice including glucocorticoids treatment in AECOPD in China.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2014
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 24, 2014
Actual (reported)January 31, 2014
Actual (reported)February 2014
Date type not reportedThis date has not been verified as actual or estimated.
August 2014
Actual (reported)August 2014
Actual (reported)Percentage of glucocorticoids treatment for AECOPD
day 1 to up to 30 days (Hospital discharge)
Percentage of oral /intravenous/ inhaled steroid therapy in patients treated with glucocorticoids, mean dosage, regimen and treatment duration via different administration route in hospital
day 1 to up to 30 days (Hospital discharge)
Percentage of antibiotics treatment for AECOPD by clinicians during the hospitalization.
day 1 to up to 30 days (Hospital discharge)
Mortality caused by AECOPD and recorded as primary cause of death by clinicians
day 1 to up to 30 days (Hospital discharge)
Percentage of antibiotics treatment via different administration route for AECOPD, mean treatment duration via different administration route in hospital
day 1 to up to 30 days (Hospital discharge)
Endotracheal intubation rate in treatment of AECOPD
day 1 to up to 30 days (Hospital discharge)
Demographic data
day 1
Year of COPD diagnosis
day 1
Any other significant medical condition or co-morbidities
day 1
The patient population will be ≥40 years of age, received hospitalization due to AECOPD since Sep, 2013. The patients should be diagnosed by GOLD 2013 as COPD at least 3 months before AECOPD based on treating physician judgment.
Research Site
Hefei, Anhui, China
Research Site
Beijing, Beijing Municipality, China
Research Site
Langfang, Hebei, China
Research Site
Baotou, Inner Mongolia, China
Research Site
Hohhot, Inner Mongolia, China
Research Site
Yinchuan, Ningxia, China
Research Site
Shanghai, Shanghai Municipality, China
Zheng JP, Zhang J, Ma LJ, Chen P, Huang M, Ou XM, Zhao ZW, Jiang SJ, Cao J, Yao W. Clinical Outcomes Of Using Nebulized Budesonide As The Initial Treatment For Acute Exacerbations Of Chronic Obstructive Pulmonary Disease: A Post-Hoc Analysis. Int J Chron Obstruct Pulmon Dis. 2019 Nov 29;14:2725-2731. doi: 10.2147/COPD.S196615. eCollection 2019.
Wanzhen Yao, Ph.D
Peking University Third Hospital
5,095 participants (actual enrollment reported by the registry).
First Submitted
January 24, 2014
First Posted
January 31, 2014
Study Start
February 2014
Date type not reportedThis date has not been verified as actual or estimated.
Comparison of Aerosol Inhalation and Intravenous Glucocorticoid in the Treatment of Severe AECOPD
Contact the study team to confirm eligibility.
Research Site
Taiyuan, Shanxi, China
Research Site
Xi’an, Shanxi, China
Research Site
Beijing, China
Research Site
Guangzhou, China
Research Site
Shanghai, China
Research Site
Tianjin, China
Primary Completion
August 2014
Actual (reported)Study Completion
August 2014
Actual (reported)Last Updated
June 15, 2016
Record last verified: 2016-06
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: